Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients
Authors:
- 5 May 2009
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 36 (10) , 1543-1550
Abstract
The aims of this study were (1) to evaluate FDG PET/CT and CT for the detection of axillary lymph node metastases in breast cancer (BC) patients and (2) to evaluate FDG PET/CT as a pre-test for the triage to sentinel lymph node biopsy (SLNB) versus axillary lymph node dissection (ALND).Keywords
This publication has 41 references indexed in Scilit:
- Recent developments in PET detector technologyPhysics in Medicine & Biology, 2008
- Breast Cancer Staging in a Single Session: Whole-Body PET/CT MammographyJournal of Nuclear Medicine, 2008
- A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastasesAnnals of Oncology, 2006
- Role of Sonography in the Diagnosis of Axillary Lymph Node Metastases in Breast Cancer: A Systematic ReviewAmerican Journal of Roentgenology, 2006
- Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissectionJournal of Surgical Oncology, 2006
- American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast CancerJournal of Clinical Oncology, 2005
- A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assuranceCancer, 2005
- Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissectionEuropean Journal of Cancer, 2005
- Role for Sentinel Lymph Node Dissection in the Management of Large (≥5 cm) Invasive Breast CancerAnnals of Surgical Oncology, 2001
- Treatment of the axilla in patients with screen-detected breast cancerBritish Journal of Surgery, 1993